Cited by 65Liver Disease Diagnosis and TreatmentPhysical Activity and HealthCardiovascular and exercise physiology

NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH

Open access
Stine, Jonathan G., Schreibman, Ian R., Faust, Alison J., Dahmus, Jessica, Stern, Benjamin, Soriano, Christopher, Rivas, Gloriany, Hummer, Breianna +6 more·2022·Hepatology

Abstract

Background and Aims: NASH is a common disease associated with increased rates of thromboembolism (TE). Although exercise training can lessen thrombotic risk in patients with vascular disease, whether similar findings are observed in patients with NASH is open for study. Approach and Results: We conducted a 20‐week randomized controlled clinical trial involving patients with biopsy‐confirmed NASH. Patients were randomly assigned (2:1 ratio) to receive either an exercise training program or standard clinical care. The primary endpoint was change in plasminogen activator inhibitor 1 (PAI‐1) level, an established thrombotic biomarker. Twenty‐eight patients were randomly assigned (18 exercise training and 10 standard clinical care). PAI‐1 level was significantly decreased by exercise training when compared to standard clinical care (−40 ± 100 vs. +70 ± 63 ng/ml; p = 0.02). Exercise training decreased MRI proton density fat fraction (MRI‐PDFF; −4.7 ± 5.6 vs. 1.2 ± 2.8% absolute liver fat; p = 0.01); 40% of exercise subjects had a ≥30% relative reduction in MRI‐PDFF (histological response threshold) compared to 13% for standard of care (p < 0.01). Exercise training improved fitness (VO 2 peak, +3.0 ± 5.6 vs. −1.8 ± 5.1 ml/kg/min; p = 0.05) in comparison to standard clinical care. Conclusions: This clinical trial showed that, independent of weight loss or dietary change, exercise training resulted in a significantly greater decrease in thrombotic risk than standard clinical care in patients with NASH, in parallel with MRI‐PDFF reduction and improvement in fitness. Future studies are required to determine whether exercise training can directly impact patient outcomes and lower rates of TE.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.32274

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [37]Piantadosi S Clinical Trials: A Methodologic Perspective, Third Edition. Hoboken, NJ: John Wiley & Sons, Inc. 2017.

Cited by

Sorted by citations

Authors
Stine, J. G., Schreibman, I. R., Faust, A. J., Dahmus, J., Stern, B., Soriano, C., Rivas, G., Hummer, B., Kimball, S. R., Geyer, N. R., Chinchilli, V. M., Loomba, R., Schmitz, K., & Sciamanna, C.
Affiliations
  • Pennsylvania State University (US)
  • Department of Public Health Sciences,The Pennsylvania State University–College of Medicine,Hershey,Pennsylvania,USA
  • University of California San Diego (US)
Corresponding author
Stine, Jonathan G.
Venue
Hepatology
Published
2022-01-22
Volume
76
Issue
1
Pages
172-185
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W4200179395
Cited by
65
References
52
Citations by year
2026: 13 · 2025: 21 · 2024: 10 · 2023: 13 · 2022: 8
FWCI
5.58
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Pennsylvania Department of Health
  • National Institutes of Health (UL1TR000127, UL1TR002014)
  • National Institute of Diabetes and Digestive and Kidney Diseases (L30 DK118601)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
nonalcoholic steatohepatitis, exercise training, thromboembolic risk, plasminogen activator inhibitor-1, liver fat reduction, proton density fat fraction, peak oxygen uptake, fitness improvement, NASH treatment
MeSH terms
Humans, Magnetic Resonance Imaging, Thrombosis, Exercise, Plasminogen Activator Inhibitor 1, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review